Focus on CNS conformational diseases and oncology, using a combination of antibodies produced to non-covalent complexes of peptide sequences, presented as liposomes. Technical and corporate overviews of company in Lausanne, Switzerland.

Company researching and developing molecular diagnostic kits for micrometastatic tumor cells in blood. Includes corporate profile, plans and contacts in Greece and Calgary, Alberta.

Develops and commercializes innovative small molecule drugs, initially for improving cancer treatments. Based in Westminster, Colorado. (Nasdaq: ALTH)

Focused on photoactivation and multi-epitopic development of foreign antibodies that activate and modulate the immune system for the treatment of ovarian tumors and multiple myeloma. Profile of company, clinic and science, with investor data and contacts at University of Alberta, Edmonton, Canada.

Develops compounds for the diagnosis of viral and non-viral induced tumour-related diseases in Innsbruck, Austria.

Company developing three approaches for cures; Chk1 kinase inhibitor, mutated p53 gene and retroviral display vaccines. Includes announcements, media releases, overview of projects incollaboration with UK, a hospital in Sydney, and corporate details at West Perth, Western Australia.

Studying the possibilities of using an immunotherapeutic approach for melanoma, breast and colorectal and tumors. Includes results of clinical research, FAQ, contact form, and profile of research partners in Canada.

Offers cytotoxicity screening for potential drugs, and ex vivo drug sensitivity cell testing, for non-Hodgkin's lymphoma, chronic and acute leukaemias, to haematologists and oncologists, as an international service from Bath, UK.

Develops organic chemistry and immunotherapy technology to produce synthetic therapeutic vaccines targeting proliferative tumors. Resources for patients and professionals and investors, with profile of company based in Edmonton, Alberta. (Nasdaq: BIOM)

Offers products for diagnosis, imaging and treatment of tumors, especially in lung. Technologies in sputum sample and pap smear screening, certifying cell lines, inflammatory focus imaging, Cu-TCPP treatment in pre-clinical development at Albuquerque, New Mexico.

Company focused on the discovery and development of anti-cancer drugs through synthetic biology of natural polyketides and rapamycin analogues. Describes technology, pipeline, and facilities near Saffron Walden, England.

Researches and develops novel therapeutic and diagnostic products to treat chronic debilitating diseases such as cancer, central nervous system disorders and autoimmune diseases. Based in Massachusetts. (Nasdaq: BLSI).

Introduction the mechanisms, with resources in oncology, vascular medicine and immunolgical disease, including possible therapies and links to related organizations, presented by Genentech, Inc.

Development and commercialization of vaccines, and treatments, such as telomere homologs and angiogenesis inhibition. Includes product pipeline, clinical trials, corporate profile and contacts in Carlsbad, California.

Develops products from the proof of concept stage to clinically viable in vitro diagnostics, in the fields of oncology and immunology. Includes patents, related publication list and profile of company in Utah.

Start-up focusing on the discovery, development and commercialisation of novel treatments for tumors and neurodegenerative diseases. Includes investor information, technology in GM-HSV targeting glioma and clinical trials in Glasgow, UK.

Preclinical-stage biopharmaceutical company that designs, develops and commercializes technologies for cancer metastasis research and treatment. Worldwide news, products and contacts in Bizkaia, Spain.

Resource treatments aimed at chronic management, focusing on anti-angiogenesis, apoptosis, B-cell biology and HER signaling. Includes sections for professionals, customers and patients, with contacts in South San Francisco, California.

Focusing on the development of delivery systems to target solid tumors, such as prostate with nanoencapsulated biotherapeutics. Includes brief overview of concepts from Chaska, Minnesota.

Offer analytical services and research partnerships in cell biology focusing on mammalian mammary gland, with applications in breast cancer and lactation. Includes examples of cytotoxicity screening, phenotyping, molecular interactions and binding studies in Ayr, Scotland.

Details of projects using resistance related to polyunsaturated fatty acids and catalase in vitro, applied in vivo to trout model. Includes publications, charity status, facilities and contacts in Olympia, Washington.

Develops and markets novel molecular therapeutics and diagnostics for tumor markers and a cell enrichment device. Includes related projects, publications and contacts in Holzkirchen, Germany.

Developing vaccines and monoclonal antibodies to delay formation of metastases of epithelial origin. Includes progress of clinical trials and invetor data for company in Vienna, Austria.

Develops pharmaceuticals relating to anti-cancer therapeutics. Includes product portfolio, with clinical trials and licensing details, conferences, international careers from San Antonio, Texas. (Nasdaq: ILXO).

Company with platform technology, called CombiSNiP, that genetically quantifies an individual's risk for development, and is involved in pharmacogenetics research on treating breast cancer. Includes corporate overview, directions and contacts in Oklahoma City.

Offers products in angiogenesis and cell growth regulation, focusing on protected ligands that target specifically to sarcomas and melanomas. Includes research and technology overview, and information for investors in Helsinki, Finland.

Researches and develops therapy products and vaccines for the prevention and treatment of tumors and leukema. Based in San Diego, California. (Nasdaq: MAXM)

Engaged in the design, development and commercialization of tumor screening systems. Information for investors, clinicians and patients, about their technologies, product timeline, and headquarters in Chicago, Illinois.

Develops diagnostics and treatments of cancer, with skeletal targeted radiotherapy. Includes information for investors, partnering and licensing, with manufacture in Texas and headquarters in Seattle, Washington. (Nasdaq: NERX)

Diagnostic and therapeutic products relating to prostate specific antigen and oncoproteins, within a division of Bayer in Cambridge, Massachusetts

Conducts research and development for marketing cell-based vaccines and human monoclonal antibody against CD55 in tumour cells. Includes explanation of products in pipeline, and clinical studies in phase II of prostate cancer vaccine at Bournemouth, and their contacts in London, UK.

Management and pipeline of cancer therapeutics licensed from the University of Southern California Keck School of Medicine in Los Angeles, California.

Company developing gene therapy system, using the E. coli enzyme, purine nucleoside phosphorylase, to induce suicide in tumor cells. Includes technology background, research, patents, publications, key staff, and contacts in Birmingham, Alabama.

Developing diagnostics to identify biomarker fingerprints for ovarian, breast, lung, prostate, and pancreatic cancer. Includes overview of company in Vacaville, California.

Developing stem cell products and therapies for hepatic diseases, offering human hepatocytes and microsomes for pre-clinical research. Overview of services, references, related links and contacts in Pathumthani, Thailand.

Oncology studies in small molecule histone deacetylase and topoisomerase II inhibitors, with clinical trials in solid tumours, CNS and extravasation. Technology and profile of company with facilities in Copenhagen and Abingdon, England.